Home Women's Health Policy Topics

Women's Health Policy

ABORTION IN THE U.S.

KFF infographic explaining who regulates mifepristone, showing four entities and their roles: the U.S. Food and Drug Administration approves and regulates medications for safety and effectiveness; state legislatures pass laws that can restrict or protect access; courts rule on legal cases affecting regulation; and Congress can pass federal legislation influencing regulation.

Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court

Louisiana sued the FDA in October 2025, claiming the FDA’s 2023 regulatory change eliminating the requirement that mifepristone be dispensed in-person—allowing it to be mailed or dispensed at retail pharmacies—harm the state's ability to enforce its abortion ban. This brief reviews the Louisiana v. FDA case and provides an overview of the other pending litigation involving mifepristone, as well as the mounting tension between states seeking to protect abortion and those banning the provision of abortion.

CONTRACEPTIve care IN THE U.S.

An Update on Medicaid, Title X and Planned Parenthood

This brief provides an update on Planned Parenthood clinic closures and participation in the Title X program amid substantial policy changes resulting in funding reductions. These changes include the One Big Beautiful Bill Act and the withholding of federal Title X funding to Planned Parenthood clinics.

SELECTED RESOURCES

Over-the-Counter Oral Contraceptive Pills

In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.

featured

A promotional image for the the KFF Health Policy 101 Issues in Women’s Health chapter

Health Policy Issues in Women’s Health

Examine the core health coverage and access issues —shaped by federal and state policies—that affect women’s health today, including health coverage and costs, reproductive health services, maternal health, mental health, and intimate partner violence.

State Profiles for Women’s Health

Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.

The essentials

  • Women’s Health Insurance Coverage

    This factsheet reviews major sources of coverage for women residing in the U.S., discusses the ACA's impact on coverage, and the coverage challenges that many women continue to face.

  • Medicaid Coverage for Women

    This data note presents key data points describing the current state of the Medicaid program as it affects women, including eligibility, reproductive health, chronic conditions, and more.

  • Dobbs: What are the Implications for Racial Disparities?

    This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.

  • State Health Facts: Women's Health Indicators

    Information on women’s health status, utilization of services, health insurance coverage, family planning and childbirth, and abortion statistics and policies.

  • Key Facts on Abortion in the United States

    This report answers some key questions about abortion in the United States and presents data collected before the overturn of Roe v. Wade.

Latest News

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: Women's Health Policy

Filter

List Grid

261 - 270 of 872 Results

  • Abortion Bans May Limit Essential Medications for Women with Chronic Conditions

    Issue Brief

    This analysis uses the 2019 IBM MarketScan claims data to look at prescriptions of methotrexate and misoprostol, two drugs that can be used to terminate pregnancies, but are also used to manage chronic conditions like cancer, autoimmune diseases, and abnormal bleeding. These drugs may be restricted in response to state abortion bans, which we find will disproportionately affect women of reproductive age who make up the majority of those who rely on these drugs.

  • Abortion Bans May Limit Access to Certain Drugs Used to Treat Women with Cancer, Autoimmune Diseases, and Ulcers

    News Release

    A new KFF analysis finds that women comprise the majority of patients who rely on certain drugs that may be restricted in response to state abortion bans. Following the Supreme Court decision to overturn Roe v. Wade, some women in abortion-banning states have reported that clinicians and pharmacists denied them access to medications like methotrexate and misoprostol that are used to manage chronic conditions but are also used for medication abortions and treatment of ectopic…

  • Fewer than Half of Employed Women Say Their Employer Offers a Paid Parental Leave or Family and Medical Leave Benefit

    News Release

    A new KFF analysis finds that fewer than half of employed women ages 18-64 say their employer offers a paid parental leave benefit, such as maternity or paternity leave (43%) or family and medical leave (44%). Access to these workplace benefits varies widely by employment status, income, location, and level of education. Women who work full-time and have higher incomes are more likely than their part-time or low-income counterparts to say their employer offers any…

  • Analysis Reveals How Abortion Boosted Democratic Candidates in Tuesday’s Midterm Election

    News Release

    While inflation was clearly at the top of voters’ minds in this year’s midterm elections, the Supreme Court decision overturning Roe v. Wade played a significant role in motivating key voting blocs that likely contributed to the Democratic party’s stronger-than-expected performance, a new analysis of KFF’s supplemental questions on the Associated Press VoteCast survey of midterm voters. About four in ten (38%) voters overall said that the Supreme Court decision ending the constitutional right to an abortion had a…

  • Contraception in the United States: A Closer Look at Experiences, Preferences, and Coverage

    Report

    This report provides a close examination of reproductive age (18-49) females' (including those who identify as women and other genders) experiences with contraception, insurance coverage, contraceptive preferences, and interactions with the health care system based on an analysis of the 2022 KFF Women's Health Survey, a nationally representative survey of females ages 18-64 in the United States.

  • Most Women are in Favor of Making Birth Control Pills Available Over the Counter without a Prescription if Research Shows they are Safe and Effective

    News Release

    A new KFF survey finds that more than three-quarters (77%) of females ages 18-49 favor making birth control pills available without a doctor’s prescription if research shows they are safe and effective. Among those who favor making birth control pills available over the counter and who currently use prescription oral contraception, 60% say they would be likely to use over-the-counter birth control pills. Most say the main reason is convenience (59%). Many females who would…

  • Updated Brief on Racial Disparities in Maternal and Infant Health

    News Release

    An updated KFF issue brief on racial disparities in maternal and infant health includes new and updated analysis of data on pregnancy-related mortality, birth risks and infant mortality. The brief reviews the underlying factors contributing to maternal and infant health racial disparities, ranging from historical and ongoing racism to differences in access to health care and coverage and other social and economic factors that drive health. With recent attention to this issue by federal and state…